-
Investor & Industry Resources to De-Risk Parkinson’s Research
… expediting Parkinson’s disease research, working tirelessly to advance global opportunities in neuroscience. Questions? … along with the development status of specific therapies. Where relevant, the report flags programs that have received … MJFF. Read the Report Target De-risking Initiatives MJFF is committed to supporting efforts that de-risk early-stage …
-
Ask the PhD: New Technologies to Treat Parkinson’s
August 19, 2020
… Our mission is to accelerate research toward new treatments, and therapies come in many forms. Many scientists are harnessing … investigating new therapies for Parkinson’s symptoms, visit our online matching tool Fox Trial Finder . Maggie …
-
The New York Times: Seeking a Shorter Path to New Drugs
November 15, 2009
… By Natasha Singer WHAT’S smaller than a breadbox, can cost $800 million or … with outside researchers on identifying novel “targets” — the disease pathways in the body that medicines are …
-
Research Roundup: Join Studies Aiming to Treat Parkinson’s Progression
June 20, 2025
… Join The Michael J. Fox Foundation’s mission to discover better treatments and, ultimately, a cure for … After the procedure, participants will need follow-up visits every three to six months for up to five years. The … Before joining the study, participants cannot have started common Parkinson’s medications like levodopa. Learn more and …
-
Introducing the Parkinson's Advocacy Toolkit: A Guide to Taking Action
July 26, 2017
… begin its annual summer recess so members can head home to meet with constituents. (The House will break from July … partners. The Foundation's new Parkinson's Advocacy Toolkit can help boost your efforts this August and year round . … on August 17 to hear more about the status of these issues. Visit the MJFF advocacy page for even more resources Ted …
-
Dr. Rachel Dolhun to TIME: "We Need the Patient Experience to Inform Us"
June 2, 2017
… In 1959, Margaret Bourke-White -- the first female photojournalist accredited to cover World War II combat zones -- courageously detailed her experience being … new ways to track and communicate about the symptoms...We need the patient experience to inform us so much, and that's …